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Abstract
Pulmonary valve pathology occurs mostly in the settings of congenital heart 
disease whether primary or as the result of repair of a variety of congenital heart 
defects. Acquired pulmonary valve disorders, albeit rare, can occur in the set-
tings of endocarditis, tumors, carcinoid syndrome, or rheumatic fever. Surgical 
options include repair and replacement of pulmonary valve. Several options for 
replacement are available, which can be tailored based on the patient’s clinical 
profile and the primary valve pathology. In this chapter, we present the surgical 
options that are currently available for pulmonary valve disorders and the cur-
rent outcomes.
Keywords: pulmonary valve replacement, endocarditis, carcinoid syndrome, 
congenital pulmonary valve stenosis, pulmonary regurgitation, bioprosthesis, 
mechanical prosthesis, Ozaki
1. Introduction
A variety of congenital and acquired pathologies results in pulmonary valve 
(PV) disease that necessitates intervention. The types of this intervention depend 
on the main pathology with transcatheter options such as balloon valvuloplasty and 
transcatheter pulmonary valve implantation gaining popularity in the current era, 
especially in the congenital settings to delay the need for a sternotomy or repeat 
surgery. Surgical options include open valvotomy for congenital pulmonary valve 
stenosis and pulmonary valve repair or replacement for many other pathologies. 
Several replacement options are available currently such as homografts, bioprosthe-
ses, and mechanical prostheses with long-term data. Other novel techniques such 
as intra-operative reconstruction of pulmonary valve leaflets using autologous or 
bovine pericardium and creation of hand-made valved conduits are being used but 
no long-term data are available for these techniques.
The focus of this chapter will be on discussing the several surgical options 
that are currently used to repair or replace the pulmonary valve and the different 
surgical approaches that are being used with reviewing the literature regarding 
outcomes. Discussion of the various pathologies involving the pulmonary valve, or 
the right ventricular outflow tract, is beyond the scope of this chapter.
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 ○ Secondary to surgical treatment of congenital lesions
• Pulmonary regurgitation after tetralogy of Fallot repair
• Homograft dysfunctions:
• Following Ross procedure
• Homografts used for reconstruction of the right ventricular 
outflow tract (RVOT):
 ○ Pulmonary atresia
 ○ Complex forms of tetralogy of Fallot
 ○ Truncus arteriosus
• Acquired
 ○ Carcinoid heart disease
 ○ Endocarditis
 ○ Pulmonary artery aneurysms
 ○ Tumors
 ○ Rheumatic heart disease
3. Surgical options for pulmonary valve pathology
3.1 Open (surgical) pulmonary valvotomy
Although transcatheter pulmonary balloon valvuloplasty is becoming a gold 
standard for isolated congenital pulmonary valve stenosis, surgical (open) pulmo-
nary valvotomy may be required in some cases that are most commonly associated 
with pulmonary annular hypoplasia (Figure 1). The advantage of the open tech-
nique is the ability to relief the right ventricular outflow tract (RVOT) obstruc-
tion in a controlled fashion via splitting the commissures of the pulmonary valve 
without causing significant regurgitation. It is also useful in addressing associated 
pulmonary annular hypoplasia via the use of a concomitant transannular patch with 
3
Surgical Options for Pulmonary Valve Pathology in the Current Era
DOI: http://dx.doi.org/10.5772/intechopen.100297
or without reconstruction of a monocusp leaflet. This technique is reported to have 
long-term excellent results in selected patients [1].
3.2 Pulmonary valve repair
Pulmonary valve repair is possible in selected congenital or acquired cases of 
pulmonary regurgitation. In the patients who underwent repair of tetralogy of 
Fallot (TOF) via a transannular patch with preservation of the native pulmonary 
leaflets and present later with dilated pulmonary artery and free pulmonary regur-
gitation, it is possible to remove the part of the transannular patch and bring the 
remaining leaflets together anteriorly thus reconstructing the anterior commissure 
and creating a bicuspid pulmonary valve [2]. In a previous report of 13 patients who 
underwent TOF repair using a transannular patch and present for pulmonary valve 
replacement (PVR), it was possible to avoid a prosthesis by repairing the pulmonary 
valve according to the technique described above [2]. The degree of regurgitation 
was markedly decreased in all patients and continued during the follow-up period. 
It is also possible to create a new leaflet from the autologous or bovine pericardium 
to form a tricuspid pulmonary valve if the other remaining two leaflets are of good 
quality thus avoiding the use of a prosthesis/homograft.
3.3 Pulmonary valve replacement
Although most valve procedures performed annually involve the aortic and/or 
mitral valves, the need for pulmonary valve replacement (PVR) is increasing due 
to the increase in patients with congenital heart disease who survive to adulthood. 
Because of the improved postoperative care and long-term survival of children under-
going repair of congenital heart defects, it is reasonable to predict that the problem of 
young adults who have developed sequelae of pulmonary regurgitation after repair of 
tetralogy of Fallot or neonatal/infant interventions for pulmonary stenosis or atresia 
will be seen with increasing frequency. In general, most authors recommend the use 
of bioprostheses or homografts for PVR in children and young adults [3].
A wide variety of materials have been utilized for PVR and or reconstruction 
of the RVOT. The most commonly used materials include autologous or bovine 
Figure 1. 
Intraoperative photo in an infant with isolated congenital pulmonary valve stenosis and hypoplastic pulmonary 




pericardium, bioprosthetic (bovine or porcine) or mechanical valves, Dacron 
conduits/grafts, bovine jugular veins, and homograft (aortic and pulmonary).
3.3.1 Autologous pericardial reconstruction (Ozaki)
The autologous pericardium has been used for decades to create aortic and/or 
pulmonary valve leaflets (one or more) and more recently has been used to cre-
ate three-leaflet aortic valves via standardized templates (Ozaki procedure) [4]. 
This procedure began in the adult population but has recently widely spread to the 
pediatric patients with aortic valve pathology with good initial and mid-term results 
in some series [5].
More recently, the same procedure has been used to create three-leaflet pulmo-
nary valves for PVR (Figures 2A–F and 3). Limited literatures are available for the 
Ozaki outcome in the pulmonary position and the majority of these are case reports 
using autologous pericardium [6] or bovine pericardium [7]. This was used in the 
setting of pulmonary artery aneurysm [8], endocarditis, and free pulmonary regur-
gitation after previous pulmonary valvotomy. We have utilized the Ozaki templates 
to create three leaflet pulmonary valves for an infant who was born with congenital 
pulmonary stenosis and hypoplastic annulus and in another child who underwent 
late repair of tetralogy of Fallot with pulmonary stenosis.
3.3.2 Valved conduits
Valved conduits used during the repair of a variety of congenital heart defects, 
most commonly tetralogy of Fallot with pulmonary atresia, truncus arteriosus, 
and Rastelli procedure for (corrected) transposition of the great arteries with 
pulmonary outflow tract obstruction. These conduits include homografts (aortic/
pulmonary/femoral vein), xenografts (bovine jugular vein), and synthetic (Dacron 
Figure 2. 
Intraoperative photos demonstrating the Ozaki technique for reconstruction of a new pulmonary valve using 
the autologous pericardium. (A) A large sheet of the anterior pericardium is harvested once the sternotomy is 
performed, (B) the pericardium is then mounted on the plate provided with the Ozaki set and is treated with 
glutaraldehyde 0.6% for 3 minutes, (C) the main pulmonary artery and the right ventricular outflow tract are 
opened longitudinally and remnants of the pulmonary valve leaflets are resected and the Ozaki sizers are used 
to determine the size of the future pericardial leaflets and to mark the suture lines and determine the location of 
the commissures, (D) the pericardial leaflets are marked using the Ozaki template, (E) the leaflets are cut with 
scissors, and (F) suturing is begun with running polypropylene along the marked lines in the right ventricular 
outflow tract. RV: right ventricle.
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conduit, expanded polytetrafluoroethylene [e-PTFE]). Several factors affect the 
choice of any of these valved conduits such as the age of the patient, the original 
pathology, previous procedure/conduit used, and availability.
3.3.3 Homografts
Homografts continued to remain the most commonly used conduits for RVOT 
reconstruction. A variety of these homografts have been used including aortic, 
pulmonary (Figure 4), and more recently valved femoral veins. The advantages 
include its availability in smaller sizes and the lack of the rigidity associated with 
other prostheses, which make them suitable conduits for neonates, infants, and 
small children. Downsides include long-term calcifications, cost, and limited avail-
ability in many countries. We reserve the use of homografts for infants and small 
Figure 4. 
Intraoperative photo for a patient who underwent a Ross procedure with a pulmonary homograft used to 
establish the right ventricular-to-pulmonary arterial confluence continuity. RV: right ventricle, Ao: ascending 
aorta, PA: pulmonary artery homograft, RA: right atrium.
Figure 3. 
Intraoperative photos showing the rest of the steps for the Ozaki reconstruction of the pulmonary valve. (A) 
Pericardial leaflets are sewn in with running polypropylene sutures, and (B) two leaflets along the posterior 
native annulus and the anterior leaflet is sewn to the undersurface of the pericardial patch (asterisk) that is 
used to augment the right ventricular outflow tract and the main pulmonary artery. RV: right ventricle.
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children due to the absence of suitable size prostheses in this age and for those with 
endocarditis as well.
3.3.4 Expanded polytetrafluoroethylene (e-PTFE) (Gore-Tex) conduits
Handmade expanded e-PTFE valves have been used with good results for RVOT 
reconstruction. The main advantages of these handmade conduits are related to 
their availability and lack of calcifications or immunological reactions, which may 
have the potential to prolong the longevity of these conduits. Current data do not 
show the inferiority of these conduits to homografts or bovine jugular veins. In 
fact, they have good biocompatibility and there was no evidence of calcifications 
in excised e-PTFE valves [9]. We personally do not have experience with this 
technique.
3.3.5 Biological prostheses
The vast majority of children and young adults who require PVR receive a 
biological valve. These prostheses carry the advantage of good durability in the 
pulmonary position and avoidance of long-term anticoagulation.
3.3.6 Mechanical prostheses
While bioprostheses are the most commonly used prostheses for PVR, the need 
for repeat operation is inevitable in children and young adults with congenital heart 
disease and mechanical prostheses may be considered in selected clinical scenarios 
to minimize the risks involved with repeat operations. The operative risk of mortal-
ity increases from 2% at the first repeat sternotomy compared with 4.7% at a fourth 
sternotomy [10]. Furthermore, Morishita and colleagues demonstrated a fourth time 
sternotomy to be a predictor of resternotomy-related injury (hazard ratio, 4.31) [11].
Most of those who are considered for mechanical PVR had a congenital  
diagnosis and underwent multiple previous sternotomies in the past (Figure 5).  
Figure 5. 
Computed tomography scan in a patient who underwent multiple previous sternotomies for an initial Rastelli 
procedure with subsequent multiple pulmonary conduits changes and has a bileaflet mechanical prosthesis in 
the pulmonary position (white circle).
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Although mechanical prostheses are durable, the need for higher-level anti-
coagulation carries its own risks, but recent reports suggest that with proper 
anticoagulation and careful monitoring, the risk of prosthetic thrombosis or 
dysfunction is low.
The issue of the performance of a mechanical prosthesis in the pulmonary 
position remains a matter of debate as there are no precise criteria for the selec-
tion of patients in whom this prosthesis would be well suited. We believe the 
ideal patient for mechanical PVR is the patient who underwent multiple previous 
sternotomies and/or requires anticoagulation for another reason such as a left-
sided mechanical prosthesis. This patient population includes those with repaired 
truncus arteriosus, prior Ross procedure, and occasionally repaired tetralogy of 
Fallot. Other indications may include those who demonstrated poor durability of 
bioprostheses.
In every case where a mechanical prosthesis is considered, the ultimate treat-
ment decision is individualized after weighing the risks of reoperation if a bio-
prosthesis is chosen, with the potential bleeding/thrombotic risks if a mechanical 
prosthesis is chosen.
4. Preoperative evaluation
Associated defects that commonly need to be addressed at the time of PVR 
include tricuspid valve repair, patch pulmonary arterioplasties, closure of residual 
shunts, and arrhythmia surgery.
Preoperative transthoracic echocardiography (TTE), computed tomography 
(CT) scan, or magnetic resonance imaging (MRI) are routinely performed. 
Cross-sectional imaging is helpful to determine the relationship of mediastinal 
structures especially the aorta and/or extracardiac conduits to the sternum and 
in assessing the pulmonary arterial anatomy. Coronary artery evaluation may be 
needed in certain circumstances to rule out obstructive coronary artery disease or 
coronary anomalies especially ones that may change the surgical plan regarding the 
PVR technique. Hemodynamic data from cardiac catheterization may be needed to 
complement other studies when there is uncertainty about the anatomy or  
ventricular function.
Intraoperative transesophageal echocardiography (TEE) is routinely performed 
before and after cardiopulmonary bypass with or without intraoperative direct 
pressure measurement across the right ventricular outflow tract.
5. Surgical approaches
5.1 Median (Re-do) sternotomy
Primary or repeat sternotomy has been the most commonly used approach. 
Technical aspects of repeat sternotomy with or without peripheral cannulation have 
been discussed previously [12].
5.2 Left posterolateral thoracotomy
Left posterolateral thoracotomy has been used as an alternate to sternotomy/
repeat sternotomy for PVR [13]. With the patient in the modified right lateral 
decubitus position, the chest is usually entered through the left fourth/fifth 
intercostal space. Normothermic cardiopulmonary bypass is established via the 
Heart Valve Surgery
8
femoral vessels. It is important to rule out the presence of any intracardiac shunts 
before proceeding with this approach. The right ventricular outflow tract and main 
pulmonary artery are identified, and once the pulmonary artery is incised, the PVR 
is proceeded as described below.
5.3 Minimally invasive left anterior thoracotomy incision
We have utilized left anterior minithoracotomy as an alternative approach to 
sternotomy for PVR in selected patients who required isolated PVR and in the 
absence of intracardiac shunts. This approach carries the advantage of being less 
invasive with rapid recovery, but careful patient selection is required. It is not advis-
able in the presence of previous pulmonary conduits, but it can be useful in cases 
where hostile mediastinum is encountered after multiple previous surgeries or in 
the presence of a large aorta in close proximity to the sternum, which increases the 
risk of repeat sternotomy.
We have previously published our technique that can be used in both primary 
and reoperative settings [14] (Figures 6A–F and 7A and B). In summary, the 
patient is positioned supine, prepped, and draped as for standard median ster-
notomy. A 6-cm horizontal incision is performed through the left third or fourth 
intercostal space. In primary operative settings, the left lung is gently retracted to 
expose the pericardium, which is then incised anterior to the left phrenic nerve to 
expose the RVOT and the main pulmonary artery. In re-operative settings, the left 
lung is usually adherent to the RVOT and/or the previously placed transannular 
patch if the pericardium was not closed after the first procedure and will need to be 
dissected off the main pulmonary artery and RVOT.
Cardiopulmonary bypass is established via the femoral vessels (open/percu-
taneously cannulated) at normothermia. It is important to achieve adequate right 
Figure 6. 
Intraoperative photos demonstrating the technical steps for pulmonary valve replacement via a minimally 
invasive left anterior thoracotomy. (A) The patient is positioned supine and a 6-cm horizontal skin incision is 
created along the left parasternal border along the left third/fourth ribs, (B) the left chest is entered through 
the left third/fourth intercostal space, and the left lung is retracted medially to expose the pericardium or the 
previously placed transannular patch, (C) in reoperative settings, pleural adhesions (asterisk) need to be taken 
down to free the lung from the right ventricular outflow tract, (D) cardiopulmonary bypass is established 
via the femoral vessels and once the heart is decompressed, the main pulmonary artery/transannular patch is 
incised longitudinally to expose the pulmonary valve, (E) remnants of the pulmonary valve leaflets are excised, 
annulus is sized and a new bioprosthesis is seated along the posterior annulus using running polypropylene 
suture, and (F) the majority of the prosthesis is seated along the native pulmonary annulus, while the anterior 
portion will be secured to the pericardial patch that will be used to augment the right ventricular outflow tract. 
P: pericardium, L: left lung, PA: main pulmonary artery.
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heart decompression during this procedure owing to the limited exposure. Along 
with routine use of vacuum-assisted venous drainage, we prefer to use a multistage 
venous cannula that is inserted via the common femoral vein and advanced all the 
way up to the superior vena cava. A vertical incision is made along the previous 
transannular patch/main pulmonary artery and remnants of pulmonary valve leaf-
lets are excised if present. The PVR is then continued as described below. The right 
side of the heart is then deaired, and the patient is weaned off cardiopulmonary 
bypass. Once TEE is satisfactory, the groin is decannulated and femoral vessels are 
repaired. A single chest drain is placed and both groin and chest incisions are then 
closed in layers. The patient is typically extubated in the operating room at the end 
of the procedure.
Our experience with this technique is in its early phase, but we have per-
formed the procedure in 6 patients (the youngest at age 13 years; 4 with previous 
tetralogy of Fallot repair). The procedure was feasible, with no conversion to 
open sternotomy in any. There was no early or late mortality. One patient devel-
oped a femoral artery pseudoaneurysm during follow-up due to percutaneous 
cannulation and required late repair. The length of stay averaged 2 days [15]. 
We believe that weight more than 30 kg is necessary for satisfactory groin vessel 
cannulation.
Figure 7. 
Intraoperative photos showing the remaining steps in pulmonary valve replacement via a left anterior 
thoracotomy. (A) A pericardial patch is commonly used to complete the augmentation of the main pulmonary 
artery and right ventricular outflow tract and the prosthesis is sewn to the undersurface of this patch with 
a running polypropylene suture, and (B) once the reconstruction is completed, the patient is weaned off 
cardiopulmonary bypass, and a single chest tube (asterisk) is placed, and the incision is closed in layers in the 
standard fashion. P: pericardial patch.
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6. Surgical techniques of pulmonary valve replacement
6.1 Sternal re-entry
Basics of primary or repeat sternotomy are followed. Sternal re-entry can be 
challenging, especially in the presence of a right-sided pathology (e.g., pulmonary 
hypertension, enlarged right heart structures, or extracardiac conduit). We prefer 
the oscillating saw for repeat sternotomy, although a craniotome can also be used.
The decision to expose the femoral vessels versus cannulating them and initiat-
ing cardiopulmonary bypass to facilitate sternotomy is individualized and is depen-
dent on the experience of the surgeon. Groin cannulation can be performed via a 
cut down with or without percutaneous right internal jugular to superior vena cava 
cannulation, which allows establishing complete cardiopulmonary bypass. Special 
attention is made to ensure adequate antegrade perfusion and adequate venous 
return of the lower extremity. This may require a chimney graft on the femoral 
artery. Axillary artery cannulation is also an option and is preferred if concomitant 
aortic surgery is being performed. If it is necessary to initiate cardiopulmonary 
bypass before or during sternal reentry, it is important to maintain a positive central 
venous pressure to avoid potential air embolism, which can occur if there is inad-
vertent entry into the right heart in the presence of an intracardiac shunt.
The procedure can be performed with aortic and a single-venous cannulation at 
normothermia in the absence of concomitant cardiac pathology that needs con-
comitant repair. It is commonly performed on the beating heart without cardiople-
gic arrest in the absence of intracardiac shunts. However, a short period of aortic 
cross-clamping and cardioplegia may be needed in challenging cases where heavily 
calcified or scarred RVOT patches or conduits are present to allow safe decalcifica-
tion and adequate debridement before removing the cross-clamp and completing 
the PVR or the new conduit placement on a beating heart.
6.2  Pulmonary valve reconstruction with autologous pericardium  
(pulmonary Ozaki)
The basic principle of the technique in harvesting the autologous pericar-
dium and creating the leaflets and sewing them is similar to the Ozaki technique 
described for aortic valve replacement.
However, there are important anatomical differences between the aortic and 
pulmonary roots that required modification of the technique to facilitate exposure 
and leaflet placement. Three possible ways to apply this technique for pulmonary 
valve reconstruction are as follows:
• If the pulmonary artery and root are adequate, the main pulmonary artery can 
be completely transected, and the leaflets are sized with the appropriate Ozaki 
sizers and suture lines are marked at the native pulmonary annulus in a similar 
fashion to the aortic procedure. The leaflets are then sewn in a similar fashion to 
the aortic technique; then, the pulmonary artery continuity is re-established.
• A second strategy is to build a valved conduit with pericardial leaflets sewn 
inside a Dacron graft on the back table; then, the conduit is implanted in a 
similar fashion to a standard pulmonary conduit.
• More commonly, the patient is presented with a hypoplastic pulmonary 
annulus that needs to be enlarged. A longitudinal pulmonary arteriotomy is 
performed, and the two posterior leaflets are created along the pulmonary 
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annulus/RVOT. The RVOT is enlarged with a pericardial patch in a way similar 
to the transannular patch technique. This patch is extended up to the future 
sinotubular junction, and the third leaflet is then sewn to the pericardial patch 
and the commissures are created followed by completing the augmentation of 
the main pulmonary artery with the remainder of the patch.
6.3 Biological/mechanical prosthesis
6.3.1 Isolated PVR
6.3.1.1 Previous transannular patch
The most common scenario occurs with a dilated right ventricular outflow 
tract from the previous repair of tetralogy of Fallot with a transannular patch 
(Figure 8A–D). In the setting, the patch is opened longitudinally and stay sutures 
are placed on both sides. Most commonly, the incision is extended proximally 
into the RVOT and distally into the proximal left main branch pulmonary artery. 
Pathological/remnant pulmonary valve cusps are resected if present. An appro-
priately sized bovine pericardial patch (our preference) is then chosen and sewn 
distally to the proximal left main branch pulmonary artery. It is not uncommon 
that concomitant branch pulmonary arterioplasty is needed in these cases. The 
patch is sewn in with running polypropylene sutures till the proposed level of the 
new pulmonary prosthesis is reached.
An appropriately sized prosthesis (biological/mechanical) is chosen and is 
secured along the native pulmonary annulus posteriorly with running polypro-
pylene suture (interrupted sutures with or without pledgets may be used some-
times based on the tissue quality). It is critical to avoid deep sutures along the 
pulmonary annulus due to the close proximity of the left main coronary artery. In 
Figure 8. 
Intraoperative photos showing the most commonly used technique for pulmonary valve replacement. (A) A 
longitudinal incision is created along the main pulmonary artery and is extended proximally into the right 
ventricular outflow tract and distally usually to the proximal left main pulmonary artery. A large pericardial 
patch is then sued to augment the main pulmonary artery is extended down to the level of the future prosthesis, 
(B) the prosthesis is secured with a running polypropylene suture along the posterior annulus, (C) the anterior 
portion of the sewing ring is then secured to the undersurface of the pericardial patch, (D) the remainder of the 




Intraoperative photo showing a surgically created pulmonary conduit by placing a bioprosthesis inside a Dacron 
tube graft which is sewn proximally and distally to the right ventricular outflow tract and the pulmonary 
arterial confluence respectively. RV: right ventricle, D: Dacron tube graft, P: pulmonary bioprosthesis.
fact, in some situations, it is better to place the prosthesis more distally (between 
the native pulmonary annulus and the pulmonary artery bifurcation) to avoid 
compromising the left coronary artery. The anterior portion of the sewing ring 
of the prosthesis is then secured to the undersurface of the patch with a running 
suture. It is important to carefully think about the orientation of the prosthesis 
before securing it to the undersurface of the patch and especially when it is a 
biological one due to its larger profile that can create a higher gradient across its 
path if not oriented properly. The prosthesis should be tilted posteriorly toward 
the pulmonary bifurcation. Also, it is important to have some redundancy in the 
pericardial patch proximal and distal to the prosthesis to ensure no gradient is cre-
ated due to a tight patch. This completes the prosthesis securement in the outflow 
tract. The rest of the bovine pericardial patch is then trimmed and sewn to the 
RVOT to complete its reconstruction.
6.3.1.2 Dilated pulmonary root with no patch
If the main pulmonary artery/outflow tract is dilated or in the presence of a 
pulmonary artery aneurysm, our technique is different. A transverse pulmonary 
arteriotomy is created, and a running or interrupted suture technique is used to 
secure the prosthesis similar to a standard aortic valve replacement. The pulmonary 
arteriotomy is then closed with a running polypropylene suture.
6.4 Valved pulmonary conduit
This is commonly used to replace a failed or dysfunctional conduit that was 
placed in a previous operation as a part of the initial repair of congenital heart 
defects such as tetralogy of Fallot with pulmonary atresia, truncus arteriosus, and 
post-Ross and Rastelli procedures.
It is critical to keep in mind the location of the left main coronary artery  
(posterior) and the left anterior descending coronary artery (lateral) in relation to 
the conduit especially when anatomical details are unclear in the setting of repeat 
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operations. The conduit itself while in most cases is located to the left of the ster-
num, and in certain congenital heart defects, it may be immediately behind the ster-
num, or in the midline such as cases of the previous repair of truncus arteriosus. This 
may require modification of the surgical technique during reoperation or initiation 
of cardiopulmonary bypass via peripheral cannulation to avoid injury to the conduit 
during repeat sternotomy. The majority of these conduits (homografts) are calcified 
to various degrees, which may increase the difficulty during the replacement. It may 
also require a complete explantation of the conduit to be able to replace a new one.
We have used different techniques in these situations depending on the quality 
of the previous conduit and the degree of calcification present:
• A longitudinal incision is placed in the anterior aspect of the conduit, while its 
posterior wall is kept intact, which minimizes injury to the left main coronary 
artery. After adequate debridement and decalcification, the new prosthesis is 
placed with a roof of pericardial patch similar to the technique described in the 
case of the transannular patch.
• If the previous conduit was a Dacron conduit, it can be dissected from the 
external fibrous peel and excised. It is important to minimize dissection of the 
floor and preserve the thick fibrous peel to allow sturdy suture placement.
• The position of the new prosthesis is critically important. In general, we place 
the prosthesis distally toward the pulmonary confluence, which minimizes 
potential compression of the left main coronary artery. Alternatively, the 
prosthesis can be placed more proximally near the level of the native pulmo-
nary annulus.
• In some scenarios, the old conduit can be completely excised, and, in these 
cases, there is a lack of continuity between the RVOT and the pulmonary 
confluence. We then create a new valved conduit using a biological/mechani-
cal prosthesis inside a Dacron tube graft (Figure 9), which is then sewn 
proximally and distally to the RVOT and the pulmonary arterial confluence 
respectably.
Regarding mechanical prostheses, it is important not to oversize them even if 
there is enough room to place a large prosthesis. Having a mild gradient across the 
prosthesis (10-15 mmHg) and a higher velocity facilitate leaflet mobility in a more 
effective way. When the prosthesis is oversized and the gradient is quite low (<5 
mmHg), then only one disk may open properly, while the other is poorly moving, 
which increases the risk of thrombosis.
Finally, the heart is adequately de-aired and cardiopulmonary bypass is discon-
tinued. Post-procedure TEE is performed, and direct pressure measurements of the 
right ventricular and pulmonary arterial pressures are obtained.
7. Outcomes
7.1 Valved conduits
Dacron conduits create thick intimal peel that requires explantation at the time 
of repeat operations. Homografts and bovine jugular veins show variable degrees 
of durability, but early degeneration and calcifications are sometimes inevitable 
(Figure 10). Added to this is their limited availability in many countries.
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A multicenter study in Japan included 794 patients (aged 14 days to 56.8 years 
old) in which e-PTFE valves were used for RVOT reconstruction at 52 Japanese 
institutes had a mean follow-up of 3.6 years (maximum 10 years) [16]. The e-PTFE 
was in the form of fan-shaped valved conduits and patches with bulging sinuses. 
The freedom from reoperation at 10 years was 95.4% in patients with conduits and 
92.3% in those with patches. No or mild pulmonary regurgitation was present in 95 
and 79.6% of those with conduits and those with patches, respectively.
7.2 Biological prostheses
In general, there are conflicting reports in the literature regarding the durability 
of various prostheses in the pulmonary position. Bando et al. observed that 94% of 
homografts have good function after 5 years; however, almost 25% had evidence of 
moderate-to-severe calcifications (Figure 11A and B) [17].
Regarding bioprosthetic conduits, a failure rate of 15% of 3 years was observed 
in the study by Cleveland et al. and calculated that 55% would have avoided a 
reoperation at 5 years [18].
In the study by Batlivala et al., the authors compared bioprostheses and homo-
graft conduits in the pulmonary position [19]. This included 254 patients aged 
10–21 years old. The median follow-up was 4.4 years. Freedom from valvar dys-
function was 72% ± 4% at 5 years and 48% ± 8% at 10 years. Freedom from RVOT 
re-interventions was 90% ± 3%, and 67% ± 5% at 5 and 10 years, respectively. No 
differences were present between bioprosthesis and homografts.
7.3 Mechanical prostheses
In a study from Mayo Clinic, 59 patients underwent mechanical PVR between 
1965 and 2013, and no valve thrombosis was observed in the settings of adequate 
anticoagulation with Warfarin. The maximum follow-up in this study extended 
to 20 years with no reoperations related to pannus formation, paravalvular leak, 
endocarditis, valve thrombosis, or prosthetic dysfunction.
The range of reported thrombosis for a mechanical PVR varies from 25 to 80% 
[20]. These thrombotic complications were reported with bileaflet mechanical 
prostheses, and none was reported in those with a tilting-disk prosthesis, although lit-
erature on this topic is spared in general. The reported complication rate of a bileaflet 
Figure 10. 
Preoperative CT scan showing calcified bovine jugular vein graft in patient who underwent repeat sternotomy 
for pulmonary conduit replacement.
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prosthesis in the pulmonary position has been about 35%. The majority of these 
thrombotic events were observed in those who were not adequately anticoagulated 
with Warfarin. Taken together, the frequency of thrombosis if the patient was not 
maintained on Warfarin was 41% (15 of 37 prostheses failed); however, if the patient 
is adequately anticoagulated, the rate of thrombosis dropped to 3.5% [21, 22]. These 
observations are seen also in the series reported by Freling et al., which spanned 26 
years and included 66 patients [23]. Actuarial freedom from reoperation was 96% at 5 
years and 89% at 10 years.
A meta-analysis of 299 patients from 19 observational studies by Dunne et al. 
documented nonstructural deterioration and valve thrombosis rates of 1.5 and 2.2%, 
respectively [24]. Redo surgery was needed in 0.9%, and thrombolysis was used 
in 0.5%. This is the largest analysis to date and confirms the low incidence of valve 
dysfunction and thrombosis for mechanical prostheses in the pulmonary position.
8. Conclusions
The pulmonary valve can be affected by a variety of congenital and acquired 
diseases. Although repair or preservation of the pulmonary valve may be possible 
in certain cases, replacement is usually required whether in primary or reoperative 
settings based on the original, pathology affecting the pulmonary valve/RVOT.
Surgical approaches can be through (repeat) sternotomy, left posterolateral 
thoracotomy, or minimally invasive left anterior minithoracotomy.
Several options are available for the replacement of the pulmonary valve with 
or without reconstruction of the RVOT. The most commonly used options include 
homografts and bioprosthetic or mechanical valves. While our first choice as a pros-
thesis for PVR is a biological valve that facilitates subsequent transcatheter inter-
ventions (Figure 12), the deciding factor between any of these options depends on 
the patient’s clinical profile especially age, original pathology/indication, prosthesis 
availability, and future expectations for this patient and therefore, it should be 
individualized. Other novel strategies such as handmade e-PTFE conduits and 
autologous pericardial leaflet reconstruction may be considered.
Figure 11. 
Preoperative images of a patient who had previous aortic homograft placed in the right ventricular outflow tract for 
repair of tetralogy of Fallot with pulmonary atresia. (A) Chest X ray showing extensive and complete calcifications 
of the homograft pulmonary conduit (white circle), (B) which is confirmed by preoperative cardiac catheterization 
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Although some of these conduits have long-term data in terms of durability and 
freedom from reintervention, literatures are limited regarding other techniques and 
the bottom line is we do not have the ideal pulmonary valve/conduit yet.
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Figure 12. 
Melody transcatheter valve is they most commonly used transcatheter option after failed pulmonary 
bioprostheses and homografts.
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